| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/15/2002 | WO2001098516A3 Siderophores-producing bifidobacteria thereby and uses thereof |
| 08/15/2002 | WO2001096875A9 Hcv antigen/antibody combination assay |
| 08/15/2002 | WO2001096582A3 Plant-signalling ligand like proteins |
| 08/15/2002 | WO2001094604A3 Method of using dna episomes to suppress gene expression in plants |
| 08/15/2002 | WO2001092321A3 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 08/15/2002 | WO2001088170A3 Plants with enhanced starch and methods for obtaining them |
| 08/15/2002 | WO2001085995A9 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene |
| 08/15/2002 | WO2001085968A9 Production of conjugated linoleic and linolenic acids in plants |
| 08/15/2002 | WO2001083819A3 Methods for designing exogenous regulatory molecules |
| 08/15/2002 | WO2001081551A9 Retinal pigment epithelial cell lines with extended life-span and their applications |
| 08/15/2002 | WO2001077177A3 Gpcr-proteins and nucleic acids encoding same |
| 08/15/2002 | WO2001072825A3 Apoptin-associating protein |
| 08/15/2002 | WO2001072824A3 Apoptin-associating protein |
| 08/15/2002 | WO2001066753A3 Human genes and gene expression products |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001064899A3 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 08/15/2002 | WO2001061039A3 5-hydroxytryptamine transporter gene polymorphisms |
| 08/15/2002 | WO2001059157A3 Process for the enumeration and identification of microorganisms |
| 08/15/2002 | WO2001057079A3 C1 inhibitor produced in the milk of transgenic mammals |
| 08/15/2002 | WO2001049104A3 Mqm mapping using haplotyped putative qtl-alleles: a simple approach for mapping qtl's in plant breeding populations |
| 08/15/2002 | WO2001046447A9 Method to improve drought tolerance in plants |
| 08/15/2002 | WO2001040309A9 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 08/15/2002 | WO2001034801A9 Recombinant gelatin in vaccines |
| 08/15/2002 | WO2001034302A9 Biochannel assay for hybridization with biomaterial |
| 08/15/2002 | WO2001033955A9 Animal models for cardiac disease |
| 08/15/2002 | WO2001032927A3 Tissue specific genes of diagnostic import |
| 08/15/2002 | WO2001032877A9 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 08/15/2002 | WO2001032222A9 Selective toxin expression in angiogenic endothelial cells |
| 08/15/2002 | WO2001029232A9 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage |
| 08/15/2002 | WO2001029211A9 Method for directed evolution by random chimeragenesis on transient templates |
| 08/15/2002 | WO2001019856A3 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 08/15/2002 | WO2001019482A9 Method for sequencing reaction cleanup by constant pressure differential ultrafiltration |
| 08/15/2002 | WO1999064067A9 Vaccine |
| 08/15/2002 | US20020112261 Transformation of monocotyledoneous plants using Agrobacterium |
| 08/15/2002 | US20020112260 Plants having resistance to multiple herbicides and its use |
| 08/15/2002 | US20020112259 Plant retroelements and methods related thereto |
| 08/15/2002 | US20020112258 Methods of using viral replicase polynucleotides and polypeptides |
| 08/15/2002 | US20020112256 Expression vector for use in generating animal model for use in evaluation and treatment of pain disorders |
| 08/15/2002 | US20020112255 Transgenic mice containing intestinal alkaline phosphatase gene disruptions |
| 08/15/2002 | US20020112254 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 08/15/2002 | US20020112252 See-through medaka |
| 08/15/2002 | US20020111746 Systems and computer software products for gene expression analysis |
| 08/15/2002 | US20020111478 Novel human ion channel protein and polynucleotides encoding the same |
| 08/15/2002 | US20020111477 Novel human transporter proteins and polynucleotides encoding the same |
| 08/15/2002 | US20020111475 Flt3-L mutants and methods of use |
| 08/15/2002 | US20020111473 Novel g protein coupled receptor |
| 08/15/2002 | US20020111472 T1-r ligand iii |
| 08/15/2002 | US20020111470 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 08/15/2002 | US20020111469 Polypeptide for use in the treatment of tumors, lung defects, inflammation and heart defects |
| 08/15/2002 | US20020111468 Nucleotide sequences coding for the sigD gene |
| 08/15/2002 | US20020111463 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 08/15/2002 | US20020111462 Nuclelotide sequences coding peptide for use in the treatment of autoimmune diseases |
| 08/15/2002 | US20020111331 FGF-affinity chromatography |
| 08/15/2002 | US20020111326 Using quaternary ammonium compound |
| 08/15/2002 | US20020111325 VEGI, an inhibitor of angiogenesis and tumor growth |
| 08/15/2002 | US20020111324 Adeno-associated virus-mediated delivery of angiogenic factors |
| 08/15/2002 | US20020111323 Genetic engineering |
| 08/15/2002 | US20020111322 Genetic engineering |
| 08/15/2002 | US20020111321 Human disease modeling using somatic gene transfer |
| 08/15/2002 | US20020111310 25219, a novel human aminotransferase and uses therefor |
| 08/15/2002 | US20020111307 46508, a novel human peptidyl-tRNA hydrolase family member and uses thereof |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020111304 Methods and compositions for treating fibrotic diseases |
| 08/15/2002 | US20020111299 Family of peptides known as xenoxins |
| 08/15/2002 | US20020111296 Thrombomodulin analogs for use in recovery of spinal cord injury |
| 08/15/2002 | US20020111294 Administering an organocobalt complex |
| 08/15/2002 | US20020110913 Human cell culture for use in the generation of erythropoietin |
| 08/15/2002 | US20020110909 Glycoprotein hormone superagonists |
| 08/15/2002 | US20020110903 Blocking of device for detecting biochemically active molecules |
| 08/15/2002 | US20020110900 Low volume chemical and biochemical reaction system |
| 08/15/2002 | US20020110898 Attenuating endogenous genes in cell; obtain cell, transform with vectors conding restriction enzymes, recover and propagate transformed cells |
| 08/15/2002 | US20020110897 Nucleotide squences coding preferential operon for use in the generation of an antibiotics and desoamine |
| 08/15/2002 | US20020110896 Expression vector coding envelope protein for use in prevention and treatment of infections; for use in gene therapy |
| 08/15/2002 | US20020110895 Nucleotide sequences coding enzymatic polypeptide for use in treatment of thrombosis and in the immune defects |
| 08/15/2002 | US20020110893 Novel human bcl-x-like proteins and polynucleotides encoding the same |
| 08/15/2002 | US20020110892 Human RNase H and compositions and uses thereof |
| 08/15/2002 | US20020110891 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of allergies, cancer, infections, graftrejection and autoimmune diseases |
| 08/15/2002 | US20020110890 Expression vector for use in the monitoring of cyclic adenosine monophosphate concentration |
| 08/15/2002 | US20020110889 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110888 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110885 Methanotrophic carbon metabolism pathway genes and enzymes |
| 08/15/2002 | US20020110884 Polypeptides controlling phytate metabolism in plants |
| 08/15/2002 | US20020110883 Novel motor proteins and methods for their use |
| 08/15/2002 | US20020110879 Nucleotide sequences coding for the ppgK gene |
| 08/15/2002 | US20020110876 Method for producing threonine and isoleucine |
| 08/15/2002 | US20020110874 Recombinant production of novel polyketides |
| 08/15/2002 | US20020110872 Cytotoxic factors for modulating cell death |
| 08/15/2002 | US20020110870 Therapeutic applications for CCR5 chemokine receptors |
| 08/15/2002 | US20020110869 Polynucleotide encoding chimeric protein and related vector, cell and method of expression thereof |
| 08/15/2002 | US20020110868 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 08/15/2002 | US20020110867 Cardiac and pancreatic protein and gene |
| 08/15/2002 | US20020110866 Nucleotide sequences coding viral capsid protein; for use in the diagnosis, treatment and/or vaccination |
| 08/15/2002 | US20020110865 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 08/15/2002 | US20020110864 Polypeptide and DNAs encoding it |
| 08/15/2002 | US20020110863 Nucleotide sequences coding enzymatic polypeptide for use as tool genetic engineering |
| 08/15/2002 | US20020110862 Novel Siglec-like gene |
| 08/15/2002 | US20020110861 Expression vectors for use as tools for controlling gene expression in genetic engineering |
| 08/15/2002 | US20020110860 Chimeric polypeptides for use as gene expression tool in genetic engineering |
| 08/15/2002 | US20020110859 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |